News
-
-
-
-
-
PRESS RELEASE
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
iAccess Alpha's Virtual Best Ideas Winter Investment Conference on December 9-10, 2025, connects top micro-cap companies and investors for high-quality insights and opportunities -
-
-
PRESS RELEASE
EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
Carl Zeiss Meditec AG terminates Maximilian Foerst's Executive Board mandate on 31 December 2025 due to Code of Conduct violation. Andreas Pecher named interim CEO from 1 January 2026 -
PRESS RELEASE
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million. Shareholders approved the takeover, with payment in cash and Mirum common stock, plus milestone payments -